久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Americas

Efficacy test of new HIV vaccine against multiple strains to be launched

Xinhua | Updated: 2019-07-16 05:46
Share
Share - WeChat
A doctor holds a red ribbon. [Photo/IC]

WASHINGTON - The US National Institutes of Health (NIH) and Janssen Pharmaceutical Companies of Johnson & Johnson announced Monday a plan to carry out an HIV vaccine efficacy trial in North America, South America and Europe.

This Phase 3 efficacy study will enroll 3,800 HIV-negative men and transgender people aged 18 to 60 years who have sex with men and/or transgender people.

The study will evaluate an investigational vaccine called Mosaico based on "mosaic" immunogens, vaccine components comprising elements from multiple HIV subtypes, aiming to induce immune responses against a wide variety of global HIV strains.

"We are committed to developing a safe and effective preventive HIV vaccine suitable for the global populations most vulnerable to HIV acquisition," said Anthony S. Fauci, director of NIH's National Institute of Allergy and Infectious Diseases.

It is anticipated to open for enrollment in the United States later this year and the clinical research will also be done in Argentina, Brazil, Italy, Mexico, Peru, Poland and Spain, according to NIH.

"We are in the process of submitting regulatory applications to the respective Health Authorities/Ethics Committees," Corina Ramers-Verhoeven, a spokesperson with Janssen Pharmaceutical Companies, told Xinhua.

The vaccine candidate may work against multiple strains of the rapidly changing virus. Currently, there is no vaccine that could bring forth broadly neutralizing antibodies, the body's most effective protection against viruses.

Initial findings from Mosaico are expected in 2023, according to Janssen.

Mosaico will be the third HIV vaccine efficacy trial in progress worldwide. The other two are Imbokodo and HVTN 702, both being tested in African countries, according to NIH.

The World Health Organization has set a goal of ending the AIDS epidemic by 2030, and a vaccine is seen as a critical tool to achieve that goal.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 色屁屁一区二区三区视频国产 | 在线91精品亚洲网站精品成人 | 波多野结衣在线中文 | 成人看片黄a在线看 | 国产精品成人免费视频 | 国产思思| 亚洲欧美精品一区天堂久久 | 国产一级片儿 | 久久精品国产午夜伦班片 | 在线观看人成网站深夜免费 | 国产乱子伦视频大全 | 精品在线视频免费观看 | 国产一区二区在线观看免费 | www.亚洲免费 | 欧美日韩一区二区三区在线观看 | 成人国产综合 | 亚洲欧美国产一区二区三区 | 婷婷的久久五月综合先锋影音 | 国内偷自第一二三区 | 精品国产一区二区三区不卡蜜臂 | 欧美一级视屏 | 美女视频黄在线观看 | 美国三级网站 | 一区二区三区 亚洲区 | 欧美日韩国产成人精品 | 美女张开腿双腿让男人桶 | 一级片高清 | 深夜福利视频在线看免费 | 国产三级在线播放线 | 欧美日韩国产一区三区 | 国产精品亚洲片在线va | 久久久久久亚洲精品中文字幕 | 久久久高清免费视频 | 播放一级毛片 | 国产在线拍揄自揄视精品不卡 | 在线视频自拍 | 九九九九九九精品免费 | 欧美精品在线一区二区三区 | 99久久精品免费看国产免费软件 | 欧美日韩一区二区三在线 | 97操碰 |